Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208669 · ClinicalTrials.gov registry record · NA
Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes
A NA study of Blood Pressure Control, sponsored by Elizabeth Pfoh.
- Recruiting
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 2
- Study locations
NCT07208669: Recruiting NA study of Blood Pressure Control, sponsored by Elizabeth Pfoh.
NCT07208669 is a NA study of Blood Pressure Control that is actively recruiting participants, run by Elizabeth Pfoh. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07208669, a NA study of Blood Pressure Control, is actively recruiting participants, sponsored by Elizabeth Pfoh.
- RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 2
- Study locations
Study Summary
The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observational evidence suggests that antihypertensive medication intensification increases harm. The proposed study tests whether a unit-based intervention (ACT-BP) can reduce antihypertensive medication intensification and provides information that is scientifically necessary for designing a cluster-randomized clinical trial that identifies the impact of intensification after experiencing an asymptomatically elevated BP on patient outcomes.
Primary Outcome
The number of new orders for antihypertensive medications or increased doses of an antihypertensive medication for patients who experience an elevated systolic BP (≥160 mmHg and ≤199 mmHg).
Conditions Studied
Interventions
- OTHER ACT-BP Intervention
Study Locations (2)
Ohio
- Cleveland Clinic Main Campus - Cleveland
- Cleveland Clinic Hillcrest - Mayfield Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2025-11-11 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT07208669 shows while recruiting
NCT07208669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Blood Pressure Control appearing as the primary indexed condition, and to 1 intervention - of which ACT-BP Intervention is the first listed.
NCT07208669 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07208669 about?
NCT07208669 is a clinical study titled "Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes". The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observa...
What is the current status of trial NCT07208669?
This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2025-11-11. Estimated completion is 2027-07-31.
What conditions does trial NCT07208669 study?
This clinical trial studies the following conditions: Blood Pressure Control.
What interventions are being tested in trial NCT07208669?
The interventions under investigation include: ACT-BP Intervention (OTHER).
Who is sponsoring clinical trial NCT07208669?
This trial is sponsored by Elizabeth Pfoh, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208669 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07208669's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI